You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 29, 2024

CLINICAL TRIALS PROFILE FOR HALFLYTELY


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for halflytely

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00164151 ↗ A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy. Completed Braintree Laboratories Phase 3 2001-06-01 The objective of this study is to determine the efficacy and safety of HalfLytely as compared to Visicol as bowel preparations before colonoscopic examination.
NCT00164164 ↗ HalfLytely Bowel Prep System for Colonoscopy Completed Braintree Laboratories Phase 3 1999-08-01 The purpose of the this study was to compare the safety and efficacy of HalfLytely (2L NULYTELY + 20mg bisacodyl) to NULYTELY for preparation prior to colonoscopy.
NCT00164177 ↗ Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy. Completed Braintree Laboratories Phase 4 2004-10-01 To evaluate the efficacy of standard HalfLYTELY® as a bowel cleansing preparation for adult patients undergoing virtual colonoscopy (VC).
NCT00278967 ↗ An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects Completed Braintree Laboratories Phase 4 2006-02-01 To compare the safety and efficacy of 2 different bowel cleansing preparations prior to colonoscopy in adult subjects.
NCT01073930 ↗ Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Split Dose PicoPrep Completed Ferring Pharmaceuticals Phase 3 2010-05-01 Subjects undergoing an elective complete colonoscopy will randomly receive either PicoPrep: 2-sachets for oral solution in two divided doses given a night before (first dose - sachet) and approximately 5 hours prior to procedure (second dose - sachet) or HalfLytely: for oral solution and two 5 mg Bisacodyl tablets, given the day before the procedure to evaluate its effectiveness, tolerability and safety.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for halflytely

Condition Name

Condition Name for halflytely
Intervention Trials
Colonoscopy 4
Bowel Preparation 2
Colon Cleansing 1
Colonic Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for halflytely
Intervention Trials
Colonic Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for halflytely

Trials by Country

Trials by Country for halflytely
Location Trials
United States 43
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for halflytely
Location Trials
North Carolina 4
Florida 3
Texas 3
Tennessee 3
New York 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for halflytely

Clinical Trial Phase

Clinical Trial Phase for halflytely
Clinical Trial Phase Trials
Phase 4 3
Phase 3 4
Phase 1/Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for halflytely
Clinical Trial Phase Trials
Completed 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for halflytely

Sponsor Name

Sponsor Name for halflytely
Sponsor Trials
Braintree Laboratories 4
Ferring Pharmaceuticals 2
Arya, Vijaypal, M.D., P.C. 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for halflytely
Sponsor Trials
Industry 8
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.